GeekWire

SEPTEMBER 1, 2020

Lumen Bioscience today announced a $16 million Series B round to help support its novel approach to rapid and low-cost drug development. It has three clinical programs to treat gastrointestinal diseases including C. Avista Development, Columbia Pacific, and local angels also participated, along with the co-founders.

Development 120

Development Biotechnology Travel Programming 120

GeekWire

AUGUST 5, 2021

Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent six years at the Bill and Melinda Gates Foundation as head of global health, died Wednesday morning of natural causes at his home in Seattle. Tadataka “Tachi” Yamada. Twitter Photo via @TachiYamada).

Development 127

Development Pharmaceuticals Biotechnology Industry 127

GeekWire

JUNE 30, 2021

based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. Absci aims to circumvent current processes for developing protein-based drugs, which often require manufacture in mammalian cells, a cumbersome and difficult method. Absci Photo).

Company 130

Company Biotechnology .Net Programming 130

GeekWire

OCTOBER 9, 2024

Phase Genomics has developed technology for sequencing DNA from wide-ranging and tricky to study organisms. Other former positions include leadership roles at the Gates Foundation and directing the global drug development program at PATH. Susan Wyrick of Sana Biotechnology.

Biotechnology 98

Biotechnology Microsoft Dell Education 98

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). Lance Solomon.

Biotechnology 101

Biotechnology Education Web Services Insurance 101

GeekWire

APRIL 12, 2023

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.

Biotechnology 98

Biotechnology Policies Energy Meeting 98

GeekWire

OCTOBER 14, 2021

Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal worth potentially more than $900 million. Immusoft’s most advanced therapeutic program is designed to treat a rare enzyme deficiency disorder, Hurler syndrome. Immusoft Photo).

Biotechnology 122

Biotechnology Licensing Programming Engineering 122

GeekWire

FEBRUARY 17, 2021

Notch Therapeutics is commercializing technologies developed in the labs of Juan-Carlos Zúñiga-Pflücker, left, chair of Notch’s scientific advisory board, and Chief Scientific Officer Peter Zandstra. The biotech company was founded in 2018 and is developing stem cell-derived immunotherapies for cancer. Notch Photo).

Biotechnology 120

Biotechnology Pharmaceuticals Research Development 120

GeekWire

JULY 19, 2021

Eliem has two lead drug candidates in development: ETX-810 for chronic pain conditions and ETX-155 for mood disorders and epilepsy. In June, Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. It aims to raise up to $80 million with the IPO. Eliem’s tech.

Biotechnology 110

Biotechnology Pharmaceuticals Groups Development 110

GeekWire

JANUARY 9, 2023

In Washington state, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies , Neoleukin Therapeutics and Sana Biotechnology all shed employees in 2022. Century launched in 2019 to develop therapies from induced pluripotent stem cells (iPSCs), which can be derived from adult tissue, and pulled in $242.7

Biotechnology 107

Biotechnology Programming Company Development 107

GeekWire

APRIL 18, 2023

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Good Therapeutics Graphic) Developing therapeutics that are active only where they are needed in the body has the potential to reduce toxic side effects.

Biotechnology 120

Biotechnology Healthcare Development Software 120

GeekWire

MARCH 9, 2023

The November layoffs coincided with a decision by Neoleukin to discontinue development of a computationally designed protein therapeutic being tested in a phase 1 trial. Neoleukin shifted its focus to developing other protein therapeutics. Neoleukin currently has 46 employees, according to a spokesperson, down from 77 in September.

Biotechnology 118

Biotechnology Licensing Programming Banking 118

GeekWire

SEPTEMBER 14, 2020

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. billion if development milestones are met, and another $1.75

Biotechnology 86

Biotechnology Pharmaceuticals Journal Licensing 86

GeekWire

SEPTEMBER 9, 2021

Cyrus Biotechnology has several drug discovery and development partnerships and also sells Cyrus Bench, a software platform for protein engineering. Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could pull in up to $1.5 Cyrus Photo). Cyrus Photo).

Biotechnology 145

Biotechnology Engineering Software Software 145

GeekWire

JULY 8, 2021

Absci, which partners with other biopharma companies to identify and develop protein-based drug candidates, has its roots in Portland. Things are different now, said Alexandre, as companies such as Seagen and Adaptive Biotechnologies go public and grow in the region. Bolstering the workforce, increasing regional connections.

Biotechnology 130

Biotechnology Industry Real Estate Company 130

GeekWire

OCTOBER 19, 2021

Sana Biotechnology raised $587 million in its IPO, Absci pulled in $200 million, and vaccine company Icosavax raised more than $180 million. She warns that regional leaders need to focus on talent development at all levels, from K-12 STEM education to research internships, to support regional biotech growth. “I

Biotechnology 124

Biotechnology Real Estate Research Industry 124

GeekWire

MAY 6, 2023

His research lab has helped forge Seattle-area startups developing a wide range of technologies. There’s a fourth biotech company being born, said Olson, who also heads the Invent at Seattle Children’s Postdoctoral Scholars Program to train students underrepresented in science for careers in biotechnology.

Biotechnology 122

Biotechnology Research Study Programming 122

GeekWire

FEBRUARY 11, 2021

The company is built on technology developed over two decades by Seattle researchers Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center and Dr. André Lieber of the University of Washington School of Medicine. (Fred Hutch Photo). In 2019, Kiem gave a TEDxSeattle talk on the science involved.

Biotechnology 128

Biotechnology Research Healthcare Engineering 128

GeekWire

DECEMBER 27, 2022

He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. “As a development stage company, we’re doing everything we can to strike the right balance between accelerating the development of our platform while seeking to extend our cash runway,” said Patel.

Industry 114

Industry Biotechnology CTO Company 114

GeekWire

JULY 21, 2020

The Seattle-based researchers are developing a nucleic acid vaccine, and more specifically a replicating RNA vaccine. “We realized that we may be on to a rapid response vaccine to the COVID-19, so we quickly accelerated that program forward,” said Deborah Fuller , a professor of microbiology and a vaccinologist.

Research 116

Research Biotechnology Study Development 116

GeekWire

NOVEMBER 21, 2024

Pultz spent her time at the UW and afterward on the cutting edge of protein design, a fast-moving field using state-of-the-art technology to develop new therapeutics, vaccines, biosensors, materials and more. She was on the forefront of the biotechnology future. She wanted to build completely new things using biology.

Pharmaceuticals 114

Pharmaceuticals CTO Biotechnology Applications 114

GeekWire

AUGUST 27, 2024

Sana Photo) — Dhaval Patel joined Sana Biotechnology as executive vice president and chief scientific officer. Aaron Bilyeu joined Cloverleaf Infrastructure as its chief development officer. Bilyeu previously worked for Meta as the senior director of site development for its data centers worldwide. The company is ranked No.

CTO Hire 100

CTO Hire Energy Data Center Biotechnology 100

GeekWire

DECEMBER 13, 2023

LinkedIn Photo) Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen has a huge pipeline for early programs and is undisputedly the anchor tenant in Pacific Northwest biotech. William Canestaro. He worked to grow the Bothell, Wash.

Biotechnology 100

Biotechnology Programming Company Development 100

GeekWire

MARCH 18, 2021

This included the eight-week Family Tech Support Center program, funded by a Tableau Foundation grant, which assisted families with IT challenges and sought to maximize the impact of Amazon’s donation of 9,000 laptops to families. Seattle-based Adaptive Biotechnologies appointed Leslie Trigg and Katey Owen to its board of directors.

Microsoft 110

Microsoft Biotechnology Pharmaceuticals Enterprise 110

GeekWire

MARCH 10, 2023

The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics. The company invested $1.2 billion this year. It reported $19.3

Artificial Intelligence 97

Artificial Intelligence Biotechnology CTO Web Services 97

GeekWire

MAY 20, 2021

The program will start in November at the UW. (UW It will host a 9-month program this November for 20-to-25 companies in partnership with Microsoft and the University of Washington’s business, engineering, and computer science schools. “This is the track,” Dooley said.

Microsoft 114

Microsoft Biotechnology Healthcare Programming 114

CIO Business Intelligence

SEPTEMBER 18, 2023

The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.

Pharmaceuticals 136

Pharmaceuticals Training Programming SAP 136

GeekWire

DECEMBER 23, 2021

Monod Bio is developing biosensors that can quickly detect viral proteins, toxins, antibodies, or other molecules. The sensors are built from engineered proteins developed at the IPD. David Shoultz , formerly head of Neoleukin’s COVID-19 program, was tapped as COO and co-founder. He didn’t have to look far.

Biotechnology 119

Biotechnology Engineering Research Software 119

The Verge

JULY 26, 2021

The company has around 20 algorithms designed to predict things like how long a patient might stay in the hospital, which patients might become seriously ill, and which might develop a deadly condition called sepsis. Like many other groups that build health algorithms, Epic doesn’t publicly share details of how the algorithms are built.

Company 88

Company Healthcare Biotechnology Financial 88

GeekWire

JANUARY 14, 2021

AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. AltPrep is currently focused on Alzheimer’s and developing tools that can detect the illness even before someone is symptomatic. Athira went public last year.

Real Estate 145

Real Estate Biotechnology Pharmaceuticals Licensing 145

GeekWire

MARCH 12, 2022

Adaptive Biotechnologies had recently doubled its headcount as it turned to COVID-19 projects, but on Wednesday the Seattle company laid off 12% of its workforce, about 100 employees. We’ve rounded up other recent life sciences and health tech news in the Pacific Northwest below: Joyce Yen, head of the UW ADVANCE program. (UW

Biotechnology 95

Biotechnology Study Pharmaceuticals Research 95

GeekWire

AUGUST 10, 2021

Following the passing of drug development pioneer Tadataka Yamada , Seattle-based biotech firm Icosovax appointed Mark McDade to succeed Yamada as chair of its board. Nautilus Biotechnology hired Karl Voss as vice president of life sciences research and development. He will be based in the company’s San Carlos, Calif.

Biotechnology 104

Biotechnology Web Services Microsoft Research 104

GeekWire

JULY 27, 2021

Alexandre believes there is more work for companies and organizations such as Life Science Washington to do in support of the industry, especially when it comes to talent development. Her work included developing health policy in Washington D.C., Born in Vancouver, Wash.,

Biotechnology 120

Biotechnology SAP Media Healthcare 120

GeekWire

OCTOBER 20, 2020

Thielke is currently managing director of Hines Asia Pacific, a global real estate investment, development and management firms. Moore previously held senior human resources roles at Mercedes-Benz’s research and development subsidiary, Apple and Samsung Electronics. Nautilus Biotechnology Photo). Nick Nelson. WTIA Photo).

Fractional CTO 84

Fractional CTO CTO Biotechnology CTO Hire 84

GeekWire

JULY 13, 2021

In addition, Fred Hutchinson Cancer Center would oversee the clinical oncology programs at both the center and UW Medical Center, according to a press release. Scientists there are developing ways to detect some cancers early by analyzing blood samples — research that can be brought more swiftly to the clinic under the new arrangement.

Research 104

Research Biotechnology Programming Examples 104

CIO Business Intelligence

JUNE 22, 2023

While Silicon Valley still pays top dollar for IT pros, the war for talent has moved beyond the technology industry, with other verticals vying for talented IT workers who have the skills to enable digital transformation, process improvement, change management, and the development of apps and services.

Industry 122

Industry Project Management Quality Assurance Insurance 122

GeekWire

JULY 15, 2021

Seattle is known for its strength in cell therapy, notes Modulus chief scientist Max Darnell , with growing biotech companies such as Sana Biotechnology and Lyell Immunopharma, as well as an arm of Bristol Myers Squib. “We want to be this discovery player that can plug into these larger incumbents,” he said.

Biotechnology 122

Biotechnology Artificial Intelligence Research Groups 122